Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Orphélie Lootens

Faculty of Pharmaceutical Sciences > Department of Bio-analysis

ORCID iD: 0000-0001-6012-0977

Add to list
- Conference Paper
- C3
Unlocking diversity : towards a comprehensive framework for physiologically based pharmacokinetic population qualification in Sub Saharan Africa

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , Sarah De Saeger (UGent) and An Vermeulen (UGent)

(2024) Population Approach Group Europe (PAGE), 32nd Annual Conference 2023, Abstracts.
Add to list
- Conference Paper
- C3
Aflatoxin B1 and efavirenz : pharmacokinetic parameter determination for the search on their interplay

Orphélie Lootens (UGent)

(2024) Interactive career day Life Sciences, Abstracts.
Add to list
- Journal Article
- A1
- open access
Exploring the impact of efavirenz on aflatoxin B1 metabolism : insights from a physiologically based pharmacokinetic model and a human liver microsome study

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Elke Gasthuys (UGent) , Sarah De Saeger (UGent) , Jan Van Bocxlaer (UGent) and An Vermeulen (UGent)

(2024) TOXINS. 16(6).
Add to list
- Journal Article
- A1
- open access
Exploration of cytochrome P450-related interactions between aflatoxin B1 and tiamulin in broiler chickens

Pan Sun (UGent) , Orphélie Lootens (UGent) , Tadele Kabeta Yadessa (UGent) , Diethard Reckelbus (UGent) , Natalia Furman, Xingyuan Cao, Suxia Zhang, Gunther Antonissen (UGent) , Siska Croubels (UGent) , Marthe De Boevre (UGent) , et al.

(2024) TOXINS. 16(3).
Add to list
Building a physiologically based pharmacokinetic model for a carcinogenic food contaminant

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Jia Ning, Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , Sarah De Saeger (UGent) and An Vermeulen (UGent)

(2023) World Mycotoxin Forum, 14th Conference, Abstracts.
Add to list
Building a physiologically based pharmacokinetic model for a carcinogenic food contaminant

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , An Vermeulen (UGent) , Jia Ning, Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) and Sarah De Saeger (UGent)

(2023) Population Approach Group Europe (PAGE), 31st Annual Conference 2023, Abstracts.
Add to list
- Journal Article
- A1
- open access
Building a human physiologically based pharmacokinetic model for aflatoxin B1 to simulate interactions with drugs

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Jia Ning, Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , Sarah De Saeger (UGent) and An Vermeulen (UGent)

(2023) PHARMACEUTICS. 15(3).
Add to list
- Journal Article
- A1
- open access
Unravelling the pharmacokinetics of aflatoxin B1 : in vitro determination of Michaelis-Menten constants, intrinsic clearance and the metabolic contribution of CYP1A2 and CYP3A4 in pooled human liver microsomes

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Sarah De Saeger (UGent)

(2022) FRONTIERS IN MICROBIOLOGY. 13.
Add to list
- Journal Article
- A1
- open access
Possible mechanisms of the interplay between drugs and mycotoxins : is there a possible impact?

Orphélie Lootens (UGent) , An Vermeulen (UGent) , Siska Croubels (UGent) , Sarah De Saeger (UGent) , Jan Van Bocxlaer (UGent) and Marthe De Boevre (UGent)

(2022) TOXINS. 14(12).
Add to list
- Conference Paper
- C3
- open access
Determination of pharmacokinetic parameters of efavirenz an aflatoxin B1 : an approach to unravel possible interactions

Orphélie Lootens (UGent) , An Vermeulen (UGent) , Elke Gasthuys (UGent) , Jan Van Bocxlaer (UGent) , Sarah De Saeger (UGent) and Marthe De Boevre (UGent)

(2022) Research Day 2022, Abstracts.

1
2

Next →